Konishi T
Dept. of Surgery, Kanto Teishin Hospital.
Gan To Kagaku Ryoho. 1999 Jun;26 Suppl 1:118-28.
As we approach the year 2000, it seems useful to look back at the progress that has been made in medicine. The author has had 25 years' experience in gastrointestinal surgery for esophageal and gastric cancers. Twenty-five years ago in the field of gastrointestinal cancer diagnosis, double-contrast radiography was the leading technology and the development of fiberscopes led to an increasing number of early cancers being detected by endoscopy combined with biopsy. The treatment of advanced cancers relied heavily on the surgical knife, with the aim of complete removal of cancer cells by through and extended combined resection. Today, greater importance is placed on limited resection that allows for the preservation of function. The combined use of chemotherapy and radiotherapy is also regarded as important in some areas, reflecting a great change in therapeutic trends. This paper examines the author's 25 years of experience as a clinical surgeon, and, in doing so, provides an outline of the changes in the treatment of esophageal and gastric cancers during the last quarter of this century. Based on this, and with a view to the 21st century, the author hopes to contribute to new developments in the treatment of esophageal and gastric cancers.
随着我们迈向2000年，回顾医学领域所取得的进展似乎很有意义。作者在食管癌和胃癌的胃肠外科方面拥有25年的经验。25年前，在胃肠癌诊断领域，双对比造影是主导技术，纤维内镜的发展使得通过内镜检查结合活检发现的早期癌症数量不断增加。晚期癌症的治疗严重依赖手术刀，目标是通过彻底和扩大的联合切除术完全清除癌细胞。如今，更强调有限切除以保留功能。化疗和放疗的联合使用在某些领域也被视为重要，这反映了治疗趋势的巨大变化。本文审视了作者作为临床外科医生25年的经验，并在此过程中概述了本世纪最后25年中食管癌和胃癌治疗方法的变化。基于此，并着眼于21世纪，作者希望为食管癌和胃癌治疗的新发展做出贡献。
